Phospho-HCLS1 (Tyr397) Antibody

What is HCLS1 and what is the significance of its Tyr397 phosphorylation site?

HCLS1 (Hematopoietic lineage cell-specific protein or Hematopoietic cell-specific Lyn substrate 1) is a substrate of antigen receptor-coupled tyrosine kinases, primarily expressed in hematopoietic cells. It plays critical roles in:

• Antigen receptor signaling for both clonal expansion and deletion in lymphoid cells

• Regulation of gene expression

• Actin cytoskeletal remodeling

• Cell adhesion and migration in immune responses

Phosphorylation at tyrosine 397 (Tyr397) is particularly significant because:

• It is essential for adhesion of natural killer cells to integrin ligand ICAM-1

• It is required for lytic synapse formation and cytolytic function

• It is specifically involved in LFA-1-based signaling but not VLA-4 mediated processes

• It occurs during immune receptor signaling but not during chemotaxis (unlike Tyr378)

This site-specific phosphorylation represents a critical regulatory mechanism that directs HCLS1's distinct functions in immune cells.

What are the primary applications for Phospho-HCLS1 (Tyr397) Antibody?

Phospho-HCLS1 (Tyr397) antibodies are widely used in multiple research applications:

These applications enable researchers to track HCLS1 activation states in various experimental contexts, from cell signaling studies to immune cell functional assays. The antibody specifically detects HCLS1 only when phosphorylated at Tyr397, making it valuable for monitoring activation status rather than just protein expression .

How do researchers validate the specificity of phospho-HCLS1 (Tyr397) antibody detection?

Validating antibody specificity is critical for reliable results. Researchers can employ several approaches:

• Blocking peptide validation: Use synthetic phosphopeptides corresponding to the region surrounding Tyr397 to compete with the endogenous protein for antibody binding. Signal disappearance confirms specificity for the phosphorylated epitope .

• Phosphatase treatment: Treating samples with phosphatase enzymes should eliminate the antibody signal if it's truly phospho-specific.

• Mutant protein controls: Compare detection between wild-type HCLS1 and Y397F mutants (where tyrosine is replaced with phenylalanine). Studies show these mutants display minimal phosphorylation and altered function .

• Stimulus-dependent phosphorylation: Verify that the antibody signal increases after treatments known to induce HCLS1 phosphorylation, such as vanadate (phosphatase inhibitor) treatment in ovarian cancer cells .

• Knockout/knockdown validation: Use HCLS1-deficient cells or knockdown models to confirm signal specificity.

Example from literature: "The GFP-tagged Y378F and Y397F HS1 mutants were phosphorylated to a lesser extent than was the wild-type protein, and the Y378F,Y397F HS1 mutant showed very little tyrosine phosphorylation" , demonstrating how mutations at these sites affect antibody detection.

What experimental conditions trigger HCLS1 Tyr397 phosphorylation?

HCLS1 Tyr397 phosphorylation can be induced through several experimental conditions:

Researchers should note that Tyr397 and Tyr378 have distinct phosphorylation patterns. While Tyr378 is predominantly phosphorylated during chemotaxis (e.g., with SDF-1α treatment), Tyr397 is not. Conversely, Tyr397 is critical for integrin-mediated adhesion signaling but Tyr378 is less involved in this context .

For optimal detection, samples should be collected at appropriate timepoints after stimulation, typically within 15-30 minutes, and phosphatase inhibitors should be included in lysis buffers to preserve phosphorylation status.

How does HCLS1 phosphorylation at Tyr397 differ functionally from phosphorylation at other sites?

HCLS1 contains multiple phosphorylation sites with distinct functions:

Research has demonstrated that these sites have separable functions: "We found evidence that the two tyrosine residues of HS1 had distinct and separable functions. Tyr397 but not Tyr378 was required for NK cell–target cell synapse formation and cytolysis, as well as for NK receptor signaling" .

Methodologically, researchers can use site-specific antibodies to distinguish these phosphorylation events or employ site-directed mutagenesis (Y397F, Y378F) to assess the functional contributions of each site in cellular assays.

What are the key kinases and phosphatases that regulate HCLS1 Tyr397 phosphorylation?

HCLS1 Tyr397 phosphorylation is regulated by a network of enzymes:

Kinases:

• Syk: A major kinase responsible for HCLS1 Tyr397 phosphorylation

• Lyn: Often works with Syk to phosphorylate HCLS1

• FES: Can phosphorylate HCLS1

• Other Src-family kinases: FYN and FGR can phosphorylate HCLS1 after cross-linking of surface IgM on B-cells

Note on sequential phosphorylation: "Phosphorylation by LYN, FYN and FGR requires prior phosphorylation by SYK or FES" , indicating a hierarchical regulation.

Phosphatases:

• Various protein tyrosine phosphatases likely regulate HCLS1, as evidenced by the enhanced phosphorylation observed after treatment with vanadate, a phosphatase inhibitor .

Interestingly, the relationship between HCLS1 and Lyn shows complex regulation: "Lyn is considered to be the kinase of HS1, and we showed that it was expressed in all OCCs evaluated in this study. Interestingly, the expression of Lyn in HS1-positive cell lines was very low, and was much higher in HS1-negative cell lines. These results suggest that HS1 in OCCs may be phosphorylated by kinases other than Lyn" .

How does phosphorylated HCLS1 (Tyr397) contribute to signaling pathways and downstream effects?

Phosphorylated HCLS1 at Tyr397 acts as a molecular switch in several key signaling pathways:

Nuclear Translocation and Transcriptional Regulation:

• Phosphorylation at Tyr397 enables HCLS1 to translocate to the nucleus

• In the nucleus, phospho-HCLS1 (Tyr397) forms complexes with transcription factors like LEF-1

• This complex regulates genes involved in myelopoiesis, including C/EBPα and LEF-1 itself

PI3K-Akt Pathway:

• HCLS1 is involved in G-CSF–triggered activation of PI3K-Akt signaling

• "Treatment of CD34+ cells with G-CSF led to phosphorylation of PI3K p85 (on Tyr458) and of Akt (on Ser473), which were both markedly reduced in cells transduced with HCLS1- or HAX1–specific shRNA"

Actin Cytoskeleton Regulation:

• HCLS1 is crucial for G-CSF–triggered F-actin rearrangement

• "G-CSF treatment of CD34+ cells led to a rapid, transient increase in F-actin content, which was abrogated by HAX1 or HCLS1 knockdown"

Integrin-Mediated Signaling:

• Phospho-HCLS1 (Tyr397) is specifically required for adhesion, cell spreading, and non-chemotactic migration in response to LFA-1-based signals

These pathways converge to regulate immune cell functions including adhesion, migration, and effector responses. Researchers can target these pathways using specific inhibitors to dissect the contribution of HCLS1 phosphorylation to cellular phenotypes.

What are the methodological considerations for studying HCLS1 phosphorylation in disease models?

When investigating HCLS1 phosphorylation in disease contexts, researchers should consider:

Sample Collection and Processing:

• Rapid sample collection and immediate processing are essential as phosphorylation states are transient

• Phosphatase inhibitors must be included in all buffers

• Flash freezing tissues preserves phosphorylation status

Disease-Specific Considerations:

• Leukemia/Lymphoma: HCLS1 is hyperactivated in chronic lymphocytic leukemia and highly expressed in AML blasts

• Heart Failure: HCLS1 is highly expressed in HF tissue samples

• Lung Cancer: HCLS1 expression is downregulated in lung adenocarcinoma samples

Analytical Approaches:

• Paired Normal-Disease Samples: Always include matched controls

• Multiplex Analysis: Examine multiple phosphorylation sites simultaneously (Tyr397, Tyr378)

• Correlation with Clinical Parameters: Link phosphorylation levels to patient outcomes

Technical Platforms:

• Tissue Microarrays: For high-throughput analysis across multiple patient samples

• Proximity Ligation Assay (PLA): For detecting protein-protein interactions involving phospho-HCLS1

  • Example: "We detected LEF-1–HCLS1 and LEF-1–phospho-HCLS1 complexes in the nuclei of G-CSF–treated CD34+ cells transduced with WT HCLS1, but not with HCLS1 NLS or HCLS1 Y397F mutants"

• Chromatin Immunoprecipitation (ChIP): For analyzing transcriptional regulatory functions

How can researchers effectively use phospho-HCLS1 (Tyr397) antibodies in flow cytometry applications?

Flow cytometry with phospho-HCLS1 (Tyr397) antibodies requires specific optimization:

Sample Preparation Protocol:

• Stimulate cells with appropriate activator (G-CSF, receptor engagement)

• Fix cells immediately (typically with paraformaldehyde)

• Permeabilize with appropriate buffer (methanol or detergent-based)

• Block with serum matching secondary antibody source

• Incubate with phospho-HCLS1 (Tyr397) antibody (typically 1:200 dilution)

• Wash thoroughly

• Add fluorochrome-conjugated secondary antibody (if primary is not directly conjugated)

• Include proper controls (described below)

Critical Controls:

• Unstimulated cells (negative control)

• Phosphatase-treated cells (specificity control)

• Isotype control antibody

• Cells expressing Y397F mutant HCLS1 (if available)

• Fluorescence-minus-one (FMO) controls

Advanced Applications:

• Multiparameter Analysis: Combine with lineage markers and other phospho-proteins

• Kinetic Studies: Analyze time-dependent phosphorylation patterns

• Pharmacological Manipulation: Assess effects of kinase/phosphatase inhibitors

• Cell Sorting: Isolate cells with specific phosphorylation patterns for downstream analysis

Conjugated antibodies (such as APC-conjugated Phospho-HCLS1 Tyr397 antibodies) are available for direct staining, which simplifies the protocol and reduces background .

What experimental approaches can elucidate the interactome of phosphorylated HCLS1 at Tyr397?

Understanding the protein interaction network of phospho-HCLS1 (Tyr397) requires sophisticated approaches:

Protein-Protein Interaction Methods:

• Co-Immunoprecipitation with Phospho-Specific Antibodies:

  • Pull down phospho-HCLS1 (Tyr397) and identify binding partners

  • Example: "In cells expressing WT HCLS1, G-CSF induced nuclear translocation of LEF-1"

• Proximity Ligation Assay (PLA):

  • Detects protein interactions with spatial resolution in situ

  • Example: "Using the Duolink in situ proximity ligation assay... we detected LEF-1–HCLS1 and LEF-1–phospho-HCLS1 complexes in the nuclei"

• BioID or APEX2 Proximity Labeling:

  • Fusion of biotin ligase to HCLS1 for labeling proximal proteins

  • Can be combined with Y397F mutants to compare interactomes

• Phospho-Protein Enrichment Combined with Mass Spectrometry:

  • Enrich phosphorylated proteins followed by proteomic analysis

  • Quantitative approaches (SILAC, TMT) can compare stimulated vs. unstimulated conditions

Genetic Manipulation Strategies:

• Site-directed mutagenesis (Y397F, Y378F, Y378F/Y397F)

• Rescue experiments in HCLS1-deficient cells

  • Example: "HCLS1−/− cells transduced with WT HCLS1 cDNA, but not with the HCLS1 Y397F or HCLS1 NLS cDNAs, showed elevated numbers of Gr-1hiCD11bhi mature granulocytes"

Functional Validation Approaches:

• Peptide competition assays with synthetic phosphopeptides

• Small molecule inhibitors targeting specific interactions

• Subcellular fractionation to track interaction dynamics between cytoplasm and nucleus

These methods have revealed that phospho-HCLS1 (Tyr397) interacts with various partners including LEF-1, HAX1, and components of the actin cytoskeleton machinery, contributing to its diverse cellular functions.